Orgenesis Inc (ORGS)
0.5486
+0.02
(+3.31%)
USD |
NASDAQ |
May 17, 16:00
0.5486
0.00 (0.00%)
After-Hours: 20:00
Orgenesis Revenue (Quarterly): 0.165M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.165M |
| September 30, 2023 | 0.11M |
| June 30, 2023 | 0.113M |
| March 31, 2023 | 0.142M |
| December 31, 2022 | 13.62M |
| September 30, 2022 | 7.988M |
| June 30, 2022 | 7.201M |
| March 31, 2022 | 7.212M |
| December 31, 2021 | 6.892M |
| September 30, 2021 | 8.676M |
| June 30, 2021 | 10.54M |
| March 31, 2021 | 9.389M |
| December 31, 2020 | 2.296M |
| September 30, 2020 | 1.729M |
| June 30, 2020 | 1.749M |
| March 31, 2020 | 1.878M |
| December 31, 2019 | -20.28M |
| September 30, 2019 | 9.121M |
| Date | Value |
|---|---|
| June 30, 2019 | 1.131M |
| March 31, 2019 | 7.301M |
| November 30, 2018 | 5.802M |
| August 31, 2018 | 6.23M |
| May 31, 2018 | 3.987M |
| February 28, 2018 | 2.636M |
| November 30, 2017 | 3.377M |
| August 31, 2017 | 2.562M |
| May 31, 2017 | 2.298M |
| February 28, 2017 | 1.852M |
| November 30, 2016 | 1.896M |
| August 31, 2016 | 1.849M |
| May 31, 2016 | 1.132M |
| February 29, 2016 | 1.52M |
| November 30, 2015 | 1.217M |
| August 31, 2015 | 0.937M |
| May 31, 2015 | 0.82M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-20.28M
Minimum
Dec 2019
13.62M
Maximum
Dec 2022
3.667M
Average
2.296M
Median
Dec 2020
Revenue (Quarterly) Benchmarks
| Altimmune Inc | 0.005M |
| Verastem Inc | -- |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Dare Bioscience Inc | 0.0093M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.623M |
| Total Expenses (Quarterly) | 5.467M |
| EPS Diluted (Quarterly) | -0.21 |
| Enterprise Value | 40.42M |
| Gross Profit Margin (Quarterly) | 1.82% |
| Profit Margin (Quarterly) | -4.01K% |
| Earnings Yield | -354.9% |
| Normalized Earnings Yield | -320.72 |